Alembic Pharmaceuticals Limited Leflunomide Export Data — India (DGFT 2022–2026)

Name: Alembic Pharmaceuticals Limited Leflunomide Export Records India — #5 Exporter, 87 Shipments, $1.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Leflunomide

India Pharmaceutical Trade Intelligence

$14.9M106 Suppliers63 CountriesHS 30049099

ExportsIndia → UNITED STATES40.5%India → MYANMAR14.2%

ImportsCANADA → India$9.9K GERMANY → India$8.0K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Alembic Pharmaceuticals Limited — Leflunomide Exporter #5 | $1.2M Trade Value | TransData Nexus | TransData Nexus

Alembic Pharmaceuticals Limited — Leflunomide Exporter Profile

Indian Pharmaceutical Exporter · #5 for Leflunomide · $1.2M export value · DGFT Verified

Alembic Pharmaceuticals Limited is the #5 Indian exporter of Leflunomide with $1.2M in export value and 87 verified shipments. Alembic Pharmaceuticals Limited holds a 7.8% market share in Leflunomide exports across 6 countries. The company exports 37 pharmaceutical products worth $127.6M across 16 therapeutic categories.

Alembic Pharmaceuticals Limited — Leflunomide Export Profile: Buyers & Destinations

Alembic Pharmaceuticals Limited Leflunomide export treemap — buyers and destination countries | TransData Nexus

Where Does Alembic Pharmaceuticals Limited Export Leflunomide?

Country	Value	Shipments	Share
GERMANY	$536.8K	34	44.0%
NETHERLANDS	$297.9K	20	24.4%
UNITED STATES	$288.7K	25	23.7%
FRANCE	$88.3K	11	7.2%
DENMARK

Who Are the Top Buyers of Leflunomide from Alembic Pharmaceuticals Limited?

Buyer	Country	Value	Orders
STADAPHARM GMBH	GERMANY	$290.7K	17
ALLOGA (NEDERLAND) B.V	NETHERLANDS	$260.0K	18
STADAPHARM GMBH.	GERMANY	$188.2K	14
J. KNIPPER & COMPANY	UNITED STATES	$114.6K	13
CSP COURNON	FRANCE	$109.8K	11
J KNIPPER COMPANY	UNITED STATES	$91.4K	7
J. KNIPPER & COMPANY,	UNITED STATES	$77.8K	2
ALLOGA NEDERLAND B V	NETHERLANDS	$37.9K	2
ALLOGA NEDERLAND BV	GERMANY	$29.1K	1
CSP COURNON ZI	FRANCE	$6.5K	1

Alembic Pharmaceuticals Limited supplies Leflunomide to 13 buyers globally. The largest buyer is STADAPHARM GMBH (GERMANY), followed by ALLOGA (NEDERLAND) B.V (NETHERLANDS) and STADAPHARM GMBH. (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Leflunomide Formulations Does Alembic Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
LEFLUNOMIDE CF 20 MG 3X10 TAB STADA NL	$202.7K	12
LEFLUNOMIDE 20 MG TABLETS 10X10'S_DE	$200.1K	9
LEFLUNOMIDE CF 10 MG 3X10 TAB STADA NL	$124.2K	9
LEFLUNOMIDE TAB USP 20MG 30T BT AP US	$77.8K	2
LEFLUNOMIDE EG 20 MG 3X10 S EG LABO FR	$62.7K	4
LEFLUNOMIDE 20 MG TABLETS 10X10 S DE	$62.3K	3
LEFLUNOMIDE 20 MG TABLETS 10X10'S DE	$50.0K	1
LEFLUNOMIDE TAB USP 20MG 30T BT AP US ASPER INVOICE	$39.7K	4
LEFLUNOMIDE TAB USP 10MG 30T BT AP US	$37.7K	1
LEFLUNOMIDE TAB USP 20MG 30T BT AP US ASPER INVOICENOS	$35.6K	6

Alembic Pharmaceuticals Limited exports 37 distinct Leflunomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEFLUNOMIDE CF 20 MG 3X10 TAB STADA NL with 12 shipments worth $202.7K.

How Does Alembic Pharmaceuticals Limited Compare to Nearest Leflunomide Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	KUSUM HEALTHCARE PRIVATE LIMITED	$1.3M	56	9	$24.0K
4	EMCURE PHARMACEUTICALS LIMITED	$1.2M	91	7	$12.8K
5	ALEMBIC PHARMACEUTICALS LIMITED ★	$1.2M	87	6	$13.3K
7	CIPLA LIMITED	$662.0K	26	2	$25.5K
8	TORRENT PHARMACEUTICALS LIMITED	$639.4K	13	5	$49.2K

Alembic Pharmaceuticals Limited ranks #5 among 106 Indian Leflunomide exporters. Average shipment value of $13.3K compared to the market average of $120.8K. The closest competitors by value are KUSUM HEALTHCARE PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Leflunomide Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	126	15.4%
SAHAR AIR	98	12.0%
SAHAR AIR CARGO ACC (INBOM4)	88	10.8%
DELHI AIR	79	9.7%
NHAVA SHEVA SEA (INNSA1)	69	8.5%
MUNDRA SEA	69	8.5%
Delhi Air	28	3.4%
Bombay Air	25	3.1%

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Leflunomide Exports

Alembic's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The recent escalation of conflicts in the Middle East, particularly the Israel-Iran tensions, has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor. Major carriers have altered their routes, opting for the longer passage around the Cape of Good Hope, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com) For Alembic, which exports to European markets, these disruptions could lead to delays and elevated shipping costs, impacting supply chain efficiency and profitability.

Conversely, the ongoing U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters. The United States' efforts to diversify its supply chain away from China have opened avenues for companies like Alembic to strengthen their presence in the U.S. market. The company's proactive approach is evident in its acquisition of Utility Therapeutics Ltd., facilitating entry into the U.S. branded drug segment. (pharma.economictimes.indiatimes.com) However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for Alembic's operations in Europe. Ensuring adherence to serialization and traceability requirements is essential to maintain market access and avoid regulatory penalties.

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Alembic Pharmaceuticals has consistently demonstrated adherence to stringent regulatory standards set by agencies such as the USFDA, WHO, and EU GMP. The company's manufacturing facilities have received approvals from various international regulatory bodies, underscoring its commitment to quality and compliance. (en.wikipedia.org) Notably, Alembic's proactive approach to addressing regulatory challenges is evident in its successful resolution of the nitrosamine issue affecting products like Duloxetine. By stabilizing the product and obtaining necessary dossier approvals, the company has reinforced its dedication to product safety and regulatory compliance. (alembiclimited.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Leflunomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Alembic Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 93 individual customs records matching Alembic Pharmaceuticals Limited exporting Leflunomide, covering 37 formulations to 6 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 63+ countries, 202+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Leflunomide

Leflunomide

Alembic Pharmaceuticals Limited — Leflunomide Exporter Profile

Alembic Pharmaceuticals Limited — Leflunomide Export Profile: Buyers & Destinations

Where Does Alembic Pharmaceuticals Limited Export Leflunomide?

Who Are the Top Buyers of Leflunomide from Alembic Pharmaceuticals Limited?

What Is India's Total Leflunomide Export Value and How Much Does Alembic Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Alembic Pharmaceuticals Limited's Leflunomide Exports?

How Does Alembic Pharmaceuticals Limited Compare to Other Indian Leflunomide Exporters?

What Leflunomide Formulations Does Alembic Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Leflunomide to Key Markets

Germany — BfArM/EMA

United States — FDA

How Does Alembic Pharmaceuticals Limited Compare to Nearest Leflunomide Exporters?

Which Indian Ports Ship Leflunomide Exports?

Leflunomide — Export Intelligence Video

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Leflunomide Exports

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Alembic Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Leflunomide Export Data from Alembic Pharmaceuticals Limited

Leflunomide Stats

Company Overview

Top Products by Alembic Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source